After COVID-19 epidemic, the supply of respiratory medicine has dropped by nearly half.

According to the HIRA's "Medicine Distribution Newsletter No. 1" published on the 5th, the supply of respiratory drugs in spring and winter since 2020 decreased by 40.6% compared to the same period last year, and the supply of Oseltamivir used to treat flu also decreased by 55.1% compared to the same period last year.

According to the period, 10,719,850 respiratory drugs (based on ATC code 'R05'cough and cold preparation OTC) were supplied from November 2019 to April 2020, while only 597,997,447 were supplied, down 40.6% from November 2020 to April 2021. During the same period, the supply of Oseltamivi